Benzinga | Dec 15, 2021 04:59AM EST

Sanofi, GlaxoSmithKline Said They Expect Data from Late-stage Clinical Trials of its Booster Dose of Their Covid-19 Vaccine Candidate in Q1 2022 vs Late 2021

-Reuters

https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-gsk-announce-positive-booster-data-their-covid-19-vaccine-candidate-2021-12-15/